Repligen Corp Revenue per Employee (RGEN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Repligen Corp  (NASDAQ: RGEN)
 

Repligen's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 10.86% in the third quarter 2026, year on year to cumulative value of $806 million, Repligen's revenue per employee grew on a trailing twelve months basis to $ 402,805. The productivity of Repligen's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 254 other companies have achieved higher revenue per employee. While Repligen's total ranking has deteriorated compared to the previous quarter from 1420 to 2036. Repligen has 2,000 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RGEN Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 10.86 % 11.93 % 14.83 % 18.12 % 21.91 %
Sales per Employee (TTM) $ 402,805 392,551 381,670 369,128 353,945
RGEN's Total Ranking # 2036 # 1420 # 1538 # 1911 #
Seq. Revenue Change 2.54 % 5.08 % -1.85 % 4.82 % 3.53 %

RGEN Company Profile >> Back to RGEN Efficiency Comparisons >> Compare RGEN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 32
Healthcare Sector # 255
Overall Market # 2036

Revenue per Employee Statistics
High Average Low
$ 400,768 $ 190,687 $ 30,730
(Dec 31 2022)   (Dec 31 2014)



Financial Statements
Repligen's Revenue MRQ $ 209 Millions Visit RGEN's Income Statement
Repligen's Revenues TTM $ 806 Millions Visit RGEN's aggregate revenue growth
What are RGEN's Sales? Visit RGEN's Sales by Segment




Other Ratios
Repligen's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
RGEN's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for RGEN's Competitors
Revenue per Employee for RGEN's Suppliers
Revenue per Employee for RGEN's Customers

You may also want to know
RGEN's Sales Growth Rates RGEN's Pe Price to earnings ratio RGEN's Receivables Turnover Ratio RGEN's Stock Quote
RGEN's Net Income Growth Rates RGEN's Ps Price to Sales ratio RGEN's Sales per Employee RGEN's Asset Turnover Ratio
RGEN's Net Margin RGEN's Pb Price to Book ratio RGEN's Financial Strength Ratios RGEN's Dividend Payout Ratio
Date modified: 2026-10-31T17:28:06+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Mannkind Corporation  698,260.14 $ 413.370  Million 592 
Rhythm Pharmaceuticals Inc   678,135.27 $ 280.748  Million 414 
Inspire Medical Systems inc   661,810.95 $ 882.194  Million 1,333 
Caredx Inc   650,190.85 $ 497.396  Million 765 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 
Si bone inc   590,928.19 $ 222.189  Million 376 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Beone Medicines Ltd   550,523.25 $ 6,606.279  Million 12,000 
Novavax inc   549,598.13 $ 411.649  Million 749 
Henry Schein Inc   549,360.00 $ 13,734.000  Million 25,000 
Bausch Health Companies Inc   547,438.42 $ 11,113.000  Million 20,300 
Iradimed Corporation  538,192.16 $ 89.340  Million 166 
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Lexicon Pharmaceuticals Inc   475,765.43 $ 38.537  Million 81 
Stryker Corp  469,642.86 $ 26,300.000  Million 56,000 
Monte Rosa Therapeutics Inc   468,833.33 $ 70.325  Million 150 
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 
Haemonetics Corporation  457,405.56 $ 1,382.737  Million 3,023 
Novocure Limited  451,955.14 $ 725.388  Million 1,605 
Omniab Inc   451,808.99 $ 40.211  Million 89 
Teladoc Health Inc   440,739.82 $ 2,468.143  Million 5,600 
Adc Therapeutics Sa  439,756.48 $ 84.873  Million 193 
Orthopediatrics Corp  437,981.73 $ 263.665  Million 602 
Vanda Pharmaceuticals Inc   430,165.10 $ 229.278  Million 533 
Axogen inc   429,141.48 $ 266.926  Million 622 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.